Abstract
Objective To elicit the pathogenetic response of the drug Asclepias curassavica in homoeopathic potencies on healthy human beings.
Methodology Drug Asclepias curassavica was proved by the Central Council for Research in Homoeopathy through randomised,
double-blind, placebo-controlled method. The study was conducted at four centres.
The drug was proved in two potencies (6C and 30C) on 67 apparently healthy volunteers
who were selected after conducting pre-trial medical examination by the medical specialists
and routine laboratory investigations. In the first phase, volunteers were given 56
doses (04 doses per day for 14 days) of placebo. In the next two phases, 56 doses
(04 doses per day for 14 days) of each potency or placebo were consumed. The symptoms
generated during the trial period were noted by the volunteers and elaborated by the
Proving Masters. The data obtained from all the four centres was compiled at proving-cum-data
processing cell at CCRH headquarters after de-coding.
Observations Out of the 44 provers who were on actual drug trial, 21 manifested symptoms. Drug
was able to produce symptoms in both the potencies more or less related to every part
of the body.
Conclusion The pathogenetic responses elicited during the proving trial expands the scope of
use of the drug Asclepias curassavica and will benefit the research scholars and clinicians. These symptoms will carry
more value when verified clinically.
Keywords
homoeopathy - pathogenetic effects - Homoeopathic Pathogenetic Trial - drug proving
-
Asclepias curassavica
